相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug
Yury N. Vorobjev
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase
Hui-Xian Wang et al.
PHYTOTHERAPY RESEARCH (2021)
Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection
Raquel Munoz-Moreno et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil
Takashi Hashimoto et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)
Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection
Yoshinori Ando et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Punicalagin is a neuraminidase inhibitor of influenza viruses
Ping Li et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions
Serena Massari et al.
ACS INFECTIOUS DISEASES (2021)
Inhibitory Activity of Honeysuckle Extracts against Influenza A VirusIn VitroandIn Vivo
Mengwei Li et al.
VIROLOGICA SINICA (2021)
Second sialic acid-binding site of influenza A virus neuraminidase: binding receptors for efficient release
Wenjuan Du et al.
FEBS JOURNAL (2021)
V292I mutation in PB2 polymerase induces increased effects of E627K on influenza H7N9 virus replication in cells
Yuqing Zhou et al.
VIRUS RESEARCH (2021)
A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137
Jingyu Zhang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection
Yucong Shi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A
Kuanglei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus
Mengdie Ye et al.
VIRUSES-BASEL (2020)
Characteristics of Seasonal Influenza Virus Activity in a Subtropical City in China, 2013-2019
Aiqin Zhu et al.
VACCINES (2020)
The Ecology and Evolution of Influenza Viruses
Michelle Wille et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
Ping Li et al.
FRONTIERS IN MICROBIOLOGY (2020)
A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants
Juliann Nzembi Makau et al.
VIRUSES-BASEL (2020)
Could Environment Affect the Mutation of H1N1 Influenza Virus?
Dong Jiang et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Put a cork in it: Plugging the M2 viral ion channel to sink influenza
Pouria H. Jalily et al.
ANTIVIRAL RESEARCH (2020)
A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases
Jiongjiong Wang et al.
FASEB JOURNAL (2020)
Antiviral properties of extracts of Streptomyces sp. SMU 03 isolated from the feces of Elephas maximus
Fangfang Li et al.
FITOTERAPIA (2020)
Probing the Neuraminidase Activity of Influenza Virus Using a Cytolysin A Protein Nanopore
Dong-Kyu Kwak et al.
ANALYTICAL CHEMISTRY (2020)
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
Michael G Ison et al.
LANCET INFECTIOUS DISEASES (2020)
Phytochemical Profiles and their Anti-inflammatory Responses Against Influenza from Traditional Chinese Medicine or Herbs
Huihui Ti
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines
Qianli Kang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza
Claire Scott et al.
PLOS PATHOGENS (2020)
Features of Nuclear Export Signals of NS2 Protein of Influenza D Virus
Lingcai Zhao et al.
VIRUSES-BASEL (2020)
In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2
Jiongjiong Wang et al.
VIRUSES-BASEL (2020)
Traditional Chinese Medicine in Treating Influenza: From Basic Science to Clinical Applications
Yibai Xiong et al.
FRONTIERS IN PHARMACOLOGY (2020)
Therapeutic Options Against the New Coronavirus: Updated Clinical and Laboratory Evidences
Amelia Carolina Lopes Fernandes et al.
FRONTIERS IN MEDICINE (2020)
Influenza A H1 and H3 Transmembrane Domains Interact Differently with Each Other and with Surrounding Membrane Lipids
Szymon Kubiszewski-Jakubiak et al.
VIRUSES-BASEL (2020)
The effects of the Xijiao Dihuang decoction combined with Yinqiao powder on miRNA-mRNA profiles in mice infected with influenza a virus
Ke Li et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2020)
AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase
Nataraj Sekhar Pagadala
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus
Maria C. White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Effect of feeding Chinese herb medicine ageratum-liquid on intestinal bacterial translocations induced by H9N2 AIV in mice
Haoran Lu et al.
VIROLOGY JOURNAL (2019)
Influenza Virus Infections and Cellular Kinases
Robert Meineke et al.
VIRUSES-BASEL (2019)
Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors
Draginja Radosevic et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Influenza A virus surface proteins are organized to help penetrate host mucus
Michael D. Vahey et al.
ELIFE (2019)
Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives
Matteo Bassetti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Biological properties of influenza A virus mutants with amino acid substitutions in the HA2 glycoprotein of the HA1/HA2 interaction region
L. Jakubcova et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Response Modifiers: Tweaking the Immune Response Against Influenza A Virus
Husni Elbahesh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir
Anne-France Georgel et al.
ANTIVIRAL RESEARCH (2019)
Structure and Function of the Influenza A Virus Non-Structural Protein 1
Chang Woo Han et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus infected mice
E. Takahashi et al.
JOURNAL OF DAIRY SCIENCE (2019)
Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2
Ning Li et al.
SCIENCE BULLETIN (2019)
Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan's unique ecosystems against influenza viruses and paramyxoviruses
Vladimir Berezin et al.
VIROLOGY JOURNAL (2019)
Susceptibility of Influenza A, B, and D Viruses to Baloxavir
Vasiliy P. Mishin et al.
EMERGING INFECTIOUS DISEASES (2019)
The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity
Jing Jin et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Implications of segment mismatch for influenza A virus evolution
Maria C. White et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Surveillance for antiviral resistance among influenza viruses circulating in Algeria during five consecutive influenza seasons (2009-2014)
Assia Ait-Aissa et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses
Ricardo Duraes-Carvalho et al.
MOLECULAR PHYLOGENETICS AND EVOLUTION (2018)
Influenza Virus
Edward C. Hutchinson
TRENDS IN MICROBIOLOGY (2018)
Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication
Nicholas Wohlgemuth et al.
JOURNAL OF VIROLOGY (2018)
Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties
Katarzyna Jakubiec-Krzesniak et al.
POLISH JOURNAL OF MICROBIOLOGY (2018)
Mutation and Epistasis in Influenza Virus Evolution
Daniel M. Lyons et al.
VIRUSES-BASEL (2018)
Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces
Hongbo Guo et al.
PLOS PATHOGENS (2018)
Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice
Ying-Jie Fu et al.
CHINESE MEDICINE (2018)
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit
Takeshi Noshi et al.
ANTIVIRAL RESEARCH (2018)
Immune History and Influenza Vaccine Effectiveness
Joseph A. Lewnard et al.
VACCINES (2018)
Identification of two residues within the NS1 of H7N9 influenza A virus that critically affect the protein stability and function
Song Wang et al.
VETERINARY RESEARCH (2018)
Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
Sung J. Yoo et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2018)
The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
Louise Ormond et al.
GENOME BIOLOGY AND EVOLUTION (2017)
Influenza A Virus M2 Protein: Roles from Ingress to Egress
Rashid Manzoor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Population Diversity and Collective Interactions during Influenza Virus Infection
Christopher B. Brooke
JOURNAL OF VIROLOGY (2017)
Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro
Zhengtu Li et al.
MOLECULES (2017)
Drug resistance in influenza A virus: the epidemiology and management
Mazhar Hussain et al.
INFECTION AND DRUG RESISTANCE (2017)
Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway
Wei Wang et al.
SCIENTIFIC REPORTS (2017)
Antiviral treatment of severe non-influenza respiratory virus infection
Nathan J. Brendish et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2017)
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
Yuewen Ding et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus
Mingyang Wang et al.
PROTEIN & CELL (2016)
Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
Evelien Vanderlinden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
An experimental evaluation of drug-induced mutational meltdown as an antiviral treatment strategy
Claudia Bank et al.
EVOLUTION (2016)
Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis
Aartjan J. W. te Velthuis et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Development of high-yield influenza B virus vaccine viruses
Jihui Ping et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome
Song Wang et al.
SCIENTIFIC REPORTS (2016)
Current and novel antiviral strategies for influenza infection
Hui-Ling Yen
CURRENT OPINION IN VIROLOGY (2016)
3-Anhydro-6-hydroxy-ophiobolin A displays high in vitro and in vivo efficacy against influenza A virus infection
Song Wang et al.
PROTEIN & CELL (2016)
Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
Alessandro Boianelli et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Epidemiological and Virological Characterization of Influenza B Virus Infections
Sivan Sharabi et al.
PLOS ONE (2016)
The role of fusion activity of influenza A viruses in their biological properties
L. Jakubcova et al.
ACTA VIROLOGICA (2016)
Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information
Brendan Nyhan et al.
VACCINE (2015)
New small-molecule drug design strategies for fighting resistant influenza A
Zuyuan Shen et al.
ACTA PHARMACEUTICA SINICA B (2015)
Synergistic Effect of Nitazoxanide with Neuraminidase Inhibitors against Influenza A Viruses In Vitro
Giuseppe Belardo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comparative structural analysis of haemagglutinin proteins from type A influenza viruses: conserved and variable features
Irene Righetto et al.
BMC BIOINFORMATICS (2014)
Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus
Haixin Ai et al.
JOURNAL OF MOLECULAR MODELING (2014)
Evolution of the Influenza A Virus Genome during Development of Oseltamivir Resistance In Vitro
Nicholas Renzette et al.
JOURNAL OF VIROLOGY (2014)
Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
Evelien Vanderlinden et al.
MEDICINAL RESEARCH REVIEWS (2014)
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex
Alicia M. Davis et al.
VIROLOGY JOURNAL (2014)
The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication
Wenjun Song et al.
NATURE COMMUNICATIONS (2014)
3-Anhydro-6-hydroxy-ophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae
Quan-Xin Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Identification of Traditional Medicinal Plant Extracts with Novel Anti-Influenza Activity
Dhivya Rajasekaran et al.
PLOS ONE (2013)
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
Miriam Cohen et al.
VIROLOGY JOURNAL (2013)
Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
Jie Yang et al.
VIRUSES-BASEL (2013)
Influenza HA Subtypes Demonstrate Divergent Phenotypes for Cleavage Activation and pH of Fusion: Implications for Host Range and Adaptation
Summer E. Galloway et al.
PLOS PATHOGENS (2013)
Recurring Influenza B Virus Infections in Seals
Rogier Bodewes et al.
EMERGING INFECTIOUS DISEASES (2013)
Emerging cellular targets for influenza antiviral agents
Konstantin H. Mueller et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion
Brian S. Hamilton et al.
VIRUSES-BASEL (2012)
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry
Shuwen Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
Shibo Jiang et al.
PROTEIN & CELL (2010)
Antiviral Role of Toll-Like Receptor-3 Agonists Against Seasonal and Avian Influenza Viruses
J. P. Wong et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target
KY Twu et al.
JOURNAL OF VIROLOGY (2006)
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics
R Wagner et al.
JOURNAL OF VIROLOGY (2000)
分享论文
